GEORGE A. SAMUEL III
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
Lineage Cell Therapeutics, Inc.
Filing Date
Source Excerpt
2024-12-09
George A. Samuel III is a director, but no software-related skills or technical background are mentioned.
Data sourced from SEC filings. Last updated: 2025-08-30